Image3_Using electronic admission data to monitor temporal trends in local medication use: Experience from an Australian tertiary teaching hospital.tif by Richard J. Woodman (8830580)

“…Of the 21 medication classes, 15 increased (p < 0.005), including antithrombotic agents; OR = 1.18 [1.16–1.21], proton pump inhibitors; OR = 1.14 [1.12–1.17], statins; OR = 1.12; [1.09–1.14], and renin-angiotensin system agents; OR = 1.06 [1.04–1.08], whilst 3 decreased (p < 0.005) including anti-inflammatory drugs (OR = 0.55; 99.5% CI = 0.53–0.58), cardiac glycosides (OR = 0.81; 99.5% CI = 0.78–0.86) and opioids (OR = 0.82; 99.5% CI = 0.79–0.83). …”

Image4_Using electronic admission data to monitor temporal trends in local medication use: Experience from an Australian tertiary teaching hospital.tif by Richard J. Woodman (8830580)

“…Of the 21 medication classes, 15 increased (p < 0.005), including antithrombotic agents; OR = 1.18 [1.16–1.21], proton pump inhibitors; OR = 1.14 [1.12–1.17], statins; OR = 1.12; [1.09–1.14], and renin-angiotensin system agents; OR = 1.06 [1.04–1.08], whilst 3 decreased (p < 0.005) including anti-inflammatory drugs (OR = 0.55; 99.5% CI = 0.53–0.58), cardiac glycosides (OR = 0.81; 99.5% CI = 0.78–0.86) and opioids (OR = 0.82; 99.5% CI = 0.79–0.83). …”

Image1_Using electronic admission data to monitor temporal trends in local medication use: Experience from an Australian tertiary teaching hospital.pdf by Richard J. Woodman (8830580)

“…Of the 21 medication classes, 15 increased (p < 0.005), including antithrombotic agents; OR = 1.18 [1.16–1.21], proton pump inhibitors; OR = 1.14 [1.12–1.17], statins; OR = 1.12; [1.09–1.14], and renin-angiotensin system agents; OR = 1.06 [1.04–1.08], whilst 3 decreased (p < 0.005) including anti-inflammatory drugs (OR = 0.55; 99.5% CI = 0.53–0.58), cardiac glycosides (OR = 0.81; 99.5% CI = 0.78–0.86) and opioids (OR = 0.82; 99.5% CI = 0.79–0.83). …”

Table1_Using electronic admission data to monitor temporal trends in local medication use: Experience from an Australian tertiary teaching hospital.docx by Richard J. Woodman (8830580)

“…Of the 21 medication classes, 15 increased (p < 0.005), including antithrombotic agents; OR = 1.18 [1.16–1.21], proton pump inhibitors; OR = 1.14 [1.12–1.17], statins; OR = 1.12; [1.09–1.14], and renin-angiotensin system agents; OR = 1.06 [1.04–1.08], whilst 3 decreased (p < 0.005) including anti-inflammatory drugs (OR = 0.55; 99.5% CI = 0.53–0.58), cardiac glycosides (OR = 0.81; 99.5% CI = 0.78–0.86) and opioids (OR = 0.82; 99.5% CI = 0.79–0.83). …”

Chemical characterization and evaluation of antimicrobial and cutaneous wound healing potentials of gold nanoparticles using Allium saralicum R.M. Fritsch by Hu, X.

Get full text
Get full text
Get full text

Data_Sheet_1_Global burden of maternal disorders attributable to malnutrition from 1990 to 2019 and predictions to 2035: worsening or improving?.docx by Tongtong Xu (4959505)

“…Both ASMR and ASDR showed a significant decreasing trend with increasing SDI. …”

Table1_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.XLSX by Yijun Wu (325401)

Table4_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.XLSX by Yijun Wu (325401)

Table2_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.XLSX by Yijun Wu (325401)

Table3_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.XLSX by Yijun Wu (325401)

Image1_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.JPEG by Yijun Wu (325401)

DataSheet1_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.PDF by Yijun Wu (325401)

Table5_Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening.XLSX by Yijun Wu (325401)

Image_4_Tannic acid supplementation in the diet of Holstein bulls: Impacts on production performance, physiological and immunological characteristics, and ruminal microbiota.pdf by Zuo Wang (8502849)

“…The average daily gain was unaffected (P > 0.05), whilst the ruminal NH₃-N was significantly decreased (P < 0.01) by TA supplementation. …”

Image_2_Tannic acid supplementation in the diet of Holstein bulls: Impacts on production performance, physiological and immunological characteristics, and ruminal microbiota.pdf by Zuo Wang (8502849)

“…The average daily gain was unaffected (P > 0.05), whilst the ruminal NH₃-N was significantly decreased (P < 0.01) by TA supplementation. …”

Image_3_Tannic acid supplementation in the diet of Holstein bulls: Impacts on production performance, physiological and immunological characteristics, and ruminal microbiota.pdf by Zuo Wang (8502849)

“…The average daily gain was unaffected (P > 0.05), whilst the ruminal NH₃-N was significantly decreased (P < 0.01) by TA supplementation. …”

Image_5_Tannic acid supplementation in the diet of Holstein bulls: Impacts on production performance, physiological and immunological characteristics, and ruminal microbiota.pdf by Zuo Wang (8502849)

“…The average daily gain was unaffected (P > 0.05), whilst the ruminal NH₃-N was significantly decreased (P < 0.01) by TA supplementation. …”

Image_1_Tannic acid supplementation in the diet of Holstein bulls: Impacts on production performance, physiological and immunological characteristics, and ruminal microbiota.pdf by Zuo Wang (8502849)

“…The average daily gain was unaffected (P > 0.05), whilst the ruminal NH₃-N was significantly decreased (P < 0.01) by TA supplementation. …”

Neurochemical identity of dFB^23E10Ո^84C10 neurons. by Joseph D. Jones (13883524)

“…<b>(G)</b> Quantification of the numbers of dFB neurons contained within the 2 Split-GAL4 lines presented in E and F. We observed 16.00 ± 0.41 (<i>n</i> = 4) dFB cells for <i>84C10-AD; ChAT-DBD</i> and 22.20 ± 0.49 (<i>n</i> = 5) dFB neurons for <i>VGlut-AD; 84C10-DBD.…”

Table1_Cusp-overlap view reduces conduction disturbances and permanent pacemaker implantation after transcatheter aortic valve replacement even with balloon-expandable and mechanic... by Tilman Stephan (11775247)

“…</p>Results<p>Of 586 patients, 282 (48.1%) underwent TAVR using COP, whereas in 304 patients (51.9%) the TCC view was applied. Using COP a significantly higher ID was achieved in Edwards SAPIEN S3 TAVR procedures (ID mean difference −1.0 mm, 95%−CI −1.9 to −0.1 mm; P = 0.029), whereas the final platform position did not differ significantly between both techniques when a Boston LOTUS Edge valve was used (ID mean difference −0.1 mm, 95%-CI −1.1 to +0.9 mm; P = 0.890). …”